I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Changes in ALBI Score and PIVKA-II within Three Months afte..:
Shinji Unome
;
Kenji Imai
;
Koji Takai
...
https://www.mdpi.com/2072-6694/14/24/6089. , 2022
Link:
https://doi.org/10.3390/cancers14246089
RT Journal T1
Changes in ALBI Score and PIVKA-II within Three Months after Commencing Atezolizumab Plus Bevacizumab Treatment Affect Overall Survival in Patients with Unresectable Hepatocellular Carcinoma
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:475b4ff57e4a477bbdbda892973d2997&Exemplar=1&LAN=DE A1 Shinji Unome A1 Kenji Imai A1 Koji Takai A1 Takao Miwa A1 Tatsunori Hanai A1 Yoichi Nishigaki A1 Hideki Hayashi A1 Takahiro Kochi A1 Shogo Shimizu A1 Junji Nagano A1 Soichi Iritani A1 Atsushi Suetsugu A1 Masahito Shimizu PB MDPI AG YR 2022 K1 hepatocellular carcinoma K1 atezolizumab K1 bevacizumab K1 prognosis factor K1 ALBI score K1 PIVKA-II K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.mdpi.com/2072-6694/14/24/6089 LK http://dx.doi.org/https://doi.org/10.3390/cancers14246089 DO https://doi.org/10.3390/cancers14246089 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)